Ready-to-use food (RUF) is increasingly used for nutritional therapy in HIV-infected individuals. However, practical guidance advising nutrition care to HIV-infected adolescents is lacking, so that little is known about the acceptability of such therapy in this vulnerable population.

This study assesses the overall acceptability and perception of a RUF-based therapy and risk factors associated with sub-optimal RUF intake in HIV-infected undernourished adolescents in Senegal.Participants 5 to 18 years of age with acute malnutrition were enrolled in 12 HIV clinics in Senegal. Participants were provided with imported RUF, according to WHO prescription weight- and age-bands (2009), until recovery or for a maximum of 9-12 months. Malnutrition and recovery were defined according to WHO growth standards.

Adherence was assessed fortnightly by self-reported RUF intake over the period. Sub-optimal RUF intake was defined as when consumption of the RUF provision was < 50%. RUF therapy acceptability and perceptions were assessed using a structured questionnaire at week 2 and focus group discussions (FGDs) at the end of the study. Factors associated with sub-optimal RUF intake at week 2 were identified using a stepwise logistic regression model.

We enrolled 173 participants, with a median age of 12.5 years (Interquartile range: 9.5-14.9), of whom 61% recovered from malnutrition within the study period.

Median follow-up duration was 66 days (21-224). RUF consumption was stable, varying between 64 and 57% of the RUF provided, throughout the follow-up. At week 2, sub-optimal RUF intake was observed in 31% of participants. Dislike of the taste of RUF (aOR = 5.0, 95% CI: 2.0-12.3), HIV non-disclosure (5.1, 1.9-13.9) and food insecurity (2.8, 1.1-7.2) were the major risk factors associated with sub-optimal RUF intake at week 2.

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC941259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC941259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC801259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC801259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC811259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC811259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC701259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF770 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC701259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF770 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC881259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF488A conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC881259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF488A conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC051259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405M conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC051259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405M conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC041259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405S conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC041259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405S conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC401259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF640R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC401259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF640R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCB1259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Biotin conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCB1259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Biotin conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCAP1259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCAP1259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCA1259-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), APC conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCR1259-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), RPE conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCP1259-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), PerCP conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNUM1259-50 Biotium 50uL 474 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), 1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCH1259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCH1259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNUB1259-100 Biotium 100uL 250.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Concentration: 0.2mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNUB1259-500 Biotium 500uL 549.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Concentration: 0.2mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC611259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF660R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC611259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF660R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC551259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF555 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC551259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF555 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC431259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF543 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC431259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF543 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC681259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF568 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC681259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF568 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC471259-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF647 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC471259-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF647 conjugate, Concentration: 0.1mg/mL

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody, Clone: NK/804

AMM00761G Leading Biology 7 ml 580.8 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker). The antibodies are raised in Mouse and are from clone NK/804. This antibody is applicable in IHC, IF

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody, Clone: NK-1

AMM00752G Leading Biology 7 ml 580.8 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker). The antibodies are raised in Mouse and are from clone NK-1. This antibody is applicable in IHC, IF

CD57 / B3GAT1 (Natural Killer Cell Marker); Clone HNK-1 & NK-1 (Concentrate)

RA0357-C.1 ScyTek Laboratories 0.1 ml 150 EUR

CD57 / B3GAT1 (Natural Killer Cell Marker); Clone HNK-1 & NK-1 (Concentrate)

RA0357-C.5 ScyTek Laboratories 0.5 ml 296.4 EUR

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody, Clone: HNK-1 + NK-1

AMM00758G Leading Biology 7 ml 580.8 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker). The antibodies are raised in Mouse and are from clone HNK-1 + NK-1. This antibody is applicable in IHC, IF

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC942403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF594 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC942403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF594 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC802403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC802403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC702403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF770 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC702403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF770 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC882403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF488A conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC882403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF488A conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC812403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC812403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF680R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC402403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF640R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC402403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF640R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC052403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405M conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC052403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405M conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC042403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405S conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC042403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF405S conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCAP2403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCAP2403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCA2403-250 Biotium 250uL 472.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), APC conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCP2403-250 Biotium 250uL 472.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), PerCP conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCR2403-250 Biotium 250uL 472.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), RPE conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCH2403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCH2403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCB2403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Biotin conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNCB2403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Biotin conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNUB2403-100 Biotium 100uL 316.8 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Concentration: 0.2mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNUB2403-50 Biotium 50uL 486 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), 1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNUB2403-500 Biotium 500uL 615.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), Concentration: 0.2mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC472403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF647 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC472403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF647 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC552403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF555 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC552403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF555 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC612403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF660R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC612403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF660R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC432403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF543 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC432403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF543 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC682403-100 Biotium 100uL 279.6 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF568 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403) Antibody

BNC682403-500 Biotium 500uL 654 EUR
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker) (GZMB/2403), CF568 conjugate, Concentration: 0.1mg/mL

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody - With BSA and Azide, Clone: NK/804

AMM00762G Leading Biology 0.05mg 475.2 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone NK/804. This antibody is applicable in IHC, IF

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody - With BSA and Azide, Clone: NK-1

AMM00753G Leading Biology 0.05mg 475.2 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone NK-1. This antibody is applicable in IHC, IF

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody - Without BSA and Azide, Clone: NK-1

AMM00754G Leading Biology 0.1mg 580.8 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone NK-1. This antibody is applicable in IHC, IF

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody - Without BSA and Azide, Clone: NK/804

AMM00763G Leading Biology 0.1mg 580.8 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone NK/804. This antibody is applicable in IHC, IF

Plasma Cell Marker Antibody

V9116-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma.

Plasma Cell Marker Antibody

V9116-20UG NSJ Bioreagents 20 ug 153.3 EUR
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma.

Plasma Cell Marker Antibody

V9116IHC-7ML NSJ Bioreagents 7 ml 349.3 EUR
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma.

Plasma Cell Marker Antibody

V9116SAF-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: It recognizes an intra-cytoplasmic antigen, which shows a very high degree of specificity for plasma cells. This antigen is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This mAb superbly recognizes normal and neoplastic plasma cells in routine formalin-fixed, paraffin-embedded tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma.

Plasma Cell Marker Antibody

V2360-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues.

Plasma Cell Marker Antibody

V2360-20UG NSJ Bioreagents 20 ug 153.3 EUR
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues.

Plasma Cell Marker Antibody

V2360IHC-7ML NSJ Bioreagents 7 ml 349.3 EUR
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues.

Plasma Cell Marker Antibody

V2360SAF-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: This antibody recognizes an intra-cytoplasmic marker antigen which shows a very high degree of specificity for plasma cells. This marker protein is present in normal as well as neoplastic plasma cells. Plasma cells, which are large lymphocytes derived from an antigen-specific B cell, secrete antibodies and are responsible for humoral immunity. Plasma cells differentiate from B cells upon stimulation by CD4+ lymphocytes. The B cell acts as an antigen-presenting cell (APC), consuming an offending pathogen, which is taken up by the B cell by phagocytosis and broken down within proteosomes. Plasma cells contain basophilic cytoplasm; their nucleus contains heterochromatin organized in a characteristic cartwheel arrangement. This marker antibody superbly recognizes normal and neoplastic plasma cells in routine formalin/paraffin tissue sections. It is of potential value in identifying myeloma or plasmacytoma in bone marrow or other tissues. It also helps differentiate lympho-plasmacytoid lymphoma from lymphocytic and follicular lymphoma. Note that this plasma cell marker antibody is not suitable for staining frozen tissues.

Myeloid Cell Marker Antibody

V9118-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: SPM298 Ab reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. Markers of myeloid cells are useful in the identification of different levels of cellular differentiation.

Myeloid Cell Marker Antibody

V9118-20UG NSJ Bioreagents 20 ug 153.3 EUR
Description: SPM298 Ab reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. Markers of myeloid cells are useful in the identification of different levels of cellular differentiation.

Myeloid Cell Marker Antibody

V9118IHC-7ML NSJ Bioreagents 7 ml 349.3 EUR
Description: SPM298 Ab reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. Markers of myeloid cells are useful in the identification of different levels of cellular differentiation.

Myeloid Cell Marker Antibody

V9118SAF-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: SPM298 Ab reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. Markers of myeloid cells are useful in the identification of different levels of cellular differentiation.

Myeloid Cell Marker Antibody

V2356-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: This antibody recognizes a 183kDa protein with DNA-binding characteristics, which is identified as a myeloid cell specific antigen. Clone BM-1 antibody reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. This type of marker is useful in the identification of different levels of cellular differentiation. BM-1 and BM-2 antibodies react with early precursor and mature forms of human myeloid cells. This mAb is useful in the identification of myelogenous leukemias, distinguishing granulocytic sarcomas from lymphoid malignancies and also in the study of differentiation and transformation of human myeloid cells. The biological function of the marker protein is not clear, although it has been proposed that it may play a role in cell differentiation.

Myeloid Cell Marker Antibody

V2356-20UG NSJ Bioreagents 20 ug 153.3 EUR
Description: This antibody recognizes a 183kDa protein with DNA-binding characteristics, which is identified as a myeloid cell specific antigen. Clone BM-1 antibody reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. This type of marker is useful in the identification of different levels of cellular differentiation. BM-1 and BM-2 antibodies react with early precursor and mature forms of human myeloid cells. This mAb is useful in the identification of myelogenous leukemias, distinguishing granulocytic sarcomas from lymphoid malignancies and also in the study of differentiation and transformation of human myeloid cells. The biological function of the marker protein is not clear, although it has been proposed that it may play a role in cell differentiation.

Myeloid Cell Marker Antibody

V2356IHC-7ML NSJ Bioreagents 7 ml 349.3 EUR
Description: This antibody recognizes a 183kDa protein with DNA-binding characteristics, which is identified as a myeloid cell specific antigen. Clone BM-1 antibody reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. This type of marker is useful in the identification of different levels of cellular differentiation. BM-1 and BM-2 antibodies react with early precursor and mature forms of human myeloid cells. This mAb is useful in the identification of myelogenous leukemias, distinguishing granulocytic sarcomas from lymphoid malignancies and also in the study of differentiation and transformation of human myeloid cells. The biological function of the marker protein is not clear, although it has been proposed that it may play a role in cell differentiation.

Myeloid Cell Marker Antibody

V2356SAF-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: This antibody recognizes a 183kDa protein with DNA-binding characteristics, which is identified as a myeloid cell specific antigen. Clone BM-1 antibody reacts with myeloid precursor cells and granulocytes in bone marrow. Its antigen appears to be restricted to M2 and M3 acute myelogenous leukemia (AML) subtypes. This type of marker is useful in the identification of different levels of cellular differentiation. BM-1 and BM-2 antibodies react with early precursor and mature forms of human myeloid cells. This mAb is useful in the identification of myelogenous leukemias, distinguishing granulocytic sarcomas from lymphoid malignancies and also in the study of differentiation and transformation of human myeloid cells. The biological function of the marker protein is not clear, although it has been proposed that it may play a role in cell differentiation.

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody - With BSA and Azide, Clone: HNK-1 + NK-1

AMM00759G Leading Biology 0.05mg 475.2 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker) - With BSA and Azide. The antibodies are raised in Mouse and are from clone HNK-1 + NK-1. This antibody is applicable in IHC, IF

Monoclonal CD57 / B3GAT1 (Natural Killer Cell Marker) Antibody - Without BSA and Azide, Clone: HNK-1 + NK-1

AMM00760G Leading Biology 0.1mg 580.8 EUR
Description: A Monoclonal antibody against Human CD57 / B3GAT1 (Natural Killer Cell Marker) - Without BSA and Azide. The antibodies are raised in Mouse and are from clone HNK-1 + NK-1. This antibody is applicable in IHC, IF

Desmin Antibody (Muscle cell marker)

F43697-0.08ML NSJ Bioreagents 0.08 ml 140.25 EUR
Description: This gene encodes a muscle-specific class III intermediate filament. Homopolymers of this protein form a stable intracytoplasmic filamentous network connecting myofibrils to each other and to the plasma membrane. Mutations in this gene are associated with desmin-related myopathy, a familial cardiac and skeletal myopathy (CSM), and with distal myopathies. [provided by RefSeq].

Desmin Antibody (Muscle cell marker)

F43697-0.4ML NSJ Bioreagents 0.4 ml 322.15 EUR
Description: This gene encodes a muscle-specific class III intermediate filament. Homopolymers of this protein form a stable intracytoplasmic filamentous network connecting myofibrils to each other and to the plasma membrane. Mutations in this gene are associated with desmin-related myopathy, a familial cardiac and skeletal myopathy (CSM), and with distal myopathies. [provided by RefSeq].

Desmin Antibody (Muscle cell marker)

F48175-0.08ML NSJ Bioreagents 0.08 ml 140.25 EUR
Description: Desmin are class-III intermediate filaments found in muscle cells. In adult striated muscle they form a fibrous network connecting myofibrils to each other and to the plasma membrane from the periphery of the Z-line structures. [UniProt]

Desmin Antibody (Muscle cell marker)

V3195-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: Cytoskeletal intermediate filaments (IFs) constitute a diverse group of proteins that are expressed in a highly tissue-specific manner. IFs are constructed from two-chain a-helical coiled-coil molecules arranged on an imperfect helical lattice, and have been widely used as markers for distinguishing individual cell types within a tissue and identifying the origins of metastatic tumors. Vimentin is an IF general marker of cells originating in the mesenchyme. Vimentin and Desmin, a related class III IF, are both expressed during skeletal muscle development. Desmin, a 469 amino acid protein found near the Z line in sarcomeres, is expressed more frequently in adult differentiated state tissues. Anti-desmin detects cells of normal smooth, skeletal, and cardiac muscles. Antibody reacts with leiomyomas, leiomyosarcoma, rhabdomyomas, rhabdomyosarcoma, and perivascular cells of glomus tumors of the skin.

Desmin Antibody (Muscle cell marker)

V3195-20UG NSJ Bioreagents 20 ug 153.3 EUR
Description: Cytoskeletal intermediate filaments (IFs) constitute a diverse group of proteins that are expressed in a highly tissue-specific manner. IFs are constructed from two-chain a-helical coiled-coil molecules arranged on an imperfect helical lattice, and have been widely used as markers for distinguishing individual cell types within a tissue and identifying the origins of metastatic tumors. Vimentin is an IF general marker of cells originating in the mesenchyme. Vimentin and Desmin, a related class III IF, are both expressed during skeletal muscle development. Desmin, a 469 amino acid protein found near the Z line in sarcomeres, is expressed more frequently in adult differentiated state tissues. Anti-desmin detects cells of normal smooth, skeletal, and cardiac muscles. Antibody reacts with leiomyomas, leiomyosarcoma, rhabdomyomas, rhabdomyosarcoma, and perivascular cells of glomus tumors of the skin.

Desmin Antibody (Muscle cell marker)

V3195SAF-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: Cytoskeletal intermediate filaments (IFs) constitute a diverse group of proteins that are expressed in a highly tissue-specific manner. IFs are constructed from two-chain a-helical coiled-coil molecules arranged on an imperfect helical lattice, and have been widely used as markers for distinguishing individual cell types within a tissue and identifying the origins of metastatic tumors. Vimentin is an IF general marker of cells originating in the mesenchyme. Vimentin and Desmin, a related class III IF, are both expressed during skeletal muscle development. Desmin, a 469 amino acid protein found near the Z line in sarcomeres, is expressed more frequently in adult differentiated state tissues. Anti-desmin detects cells of normal smooth, skeletal, and cardiac muscles. Antibody reacts with leiomyomas, leiomyosarcoma, rhabdomyomas, rhabdomyosarcoma, and perivascular cells of glomus tumors of the skin.

Desmin Antibody (Muscle cell marker)

V7478-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: Cytoskeletal intermediate filaments (IFs) constitute a diverse group of proteins that are expressed in a highly tissue-specific manner. IFs are constructed from two-chain alpha-helical coiled-coil molecules arranged on an imperfect helical lattice, and have been widely used as markers for distinguishing individual cell types within a tissue and identifying the origins of metastatic tumors. Vimentin is an IF general marker of cells originating in the mesenchyme. Vimentin and Desmin, a related class III IF, are both expressed during skeletal muscle development. Desmin, a 469 amino acid protein found near the Z line in sarcomeres, is expressed more frequently in adult differentiated state tissues. Anti-desmin detects cells of normal smooth, skeletal, and cardiac muscles. Antibody reacts with leiomyomas, leiomyosarcoma, rhabdomyomas, rhabdomyosarcoma, and perivascular cells of glomus tumors of the skin.

Desmin Antibody (Muscle cell marker)

V7478-20UG NSJ Bioreagents 20 ug 153.3 EUR
Description: Cytoskeletal intermediate filaments (IFs) constitute a diverse group of proteins that are expressed in a highly tissue-specific manner. IFs are constructed from two-chain alpha-helical coiled-coil molecules arranged on an imperfect helical lattice, and have been widely used as markers for distinguishing individual cell types within a tissue and identifying the origins of metastatic tumors. Vimentin is an IF general marker of cells originating in the mesenchyme. Vimentin and Desmin, a related class III IF, are both expressed during skeletal muscle development. Desmin, a 469 amino acid protein found near the Z line in sarcomeres, is expressed more frequently in adult differentiated state tissues. Anti-desmin detects cells of normal smooth, skeletal, and cardiac muscles. Antibody reacts with leiomyomas, leiomyosarcoma, rhabdomyomas, rhabdomyosarcoma, and perivascular cells of glomus tumors of the skin.

Desmin Antibody (Muscle cell marker)

V7478IHC-7ML NSJ Bioreagents 7 ml 349.3 EUR
Description: Cytoskeletal intermediate filaments (IFs) constitute a diverse group of proteins that are expressed in a highly tissue-specific manner. IFs are constructed from two-chain alpha-helical coiled-coil molecules arranged on an imperfect helical lattice, and have been widely used as markers for distinguishing individual cell types within a tissue and identifying the origins of metastatic tumors. Vimentin is an IF general marker of cells originating in the mesenchyme. Vimentin and Desmin, a related class III IF, are both expressed during skeletal muscle development. Desmin, a 469 amino acid protein found near the Z line in sarcomeres, is expressed more frequently in adult differentiated state tissues. Anti-desmin detects cells of normal smooth, skeletal, and cardiac muscles. Antibody reacts with leiomyomas, leiomyosarcoma, rhabdomyomas, rhabdomyosarcoma, and perivascular cells of glomus tumors of the skin.

Desmin Antibody (Muscle cell marker)

V7478SAF-100UG NSJ Bioreagents 100 ug 349.3 EUR
Description: Cytoskeletal intermediate filaments (IFs) constitute a diverse group of proteins that are expressed in a highly tissue-specific manner. IFs are constructed from two-chain alpha-helical coiled-coil molecules arranged on an imperfect helical lattice, and have been widely used as markers for distinguishing individual cell types within a tissue and identifying the origins of metastatic tumors. Vimentin is an IF general marker of cells originating in the mesenchyme. Vimentin and Desmin, a related class III IF, are both expressed during skeletal muscle development. Desmin, a 469 amino acid protein found near the Z line in sarcomeres, is expressed more frequently in adult differentiated state tissues. Anti-desmin detects cells of normal smooth, skeletal, and cardiac muscles. Antibody reacts with leiomyomas, leiomyosarcoma, rhabdomyomas, rhabdomyosarcoma, and perivascular cells of glomus tumors of the skin.

Polyclonal Granzyme B (NK/T-Cell Lymphoma Marker) Antibody - With BSA and Azide

APR00543G Leading Biology 50 ug 475.2 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Granzyme B (NK/T-Cell Lymphoma Marker) - With BSA and Azide. This antibody is tested and proven to work in the following applications:

Polyclonal Granzyme B (NK/T-Cell Lymphoma Marker) Antibody - Without BSA and Azide

APR00544G Leading Biology 0.1mg 580.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Granzyme B (NK/T-Cell Lymphoma Marker) - Without BSA and Azide. This antibody is tested and proven to work in the following applications:

Myeloid Cell Marker (Macrophage / Granulocyte Marker); Clone BM-1 (Concentrate)

RA0400-C.1 ScyTek Laboratories 0.1 ml 150 EUR

Myeloid Cell Marker (Macrophage / Granulocyte Marker); Clone BM-1 (Concentrate)

RA0400-C.5 ScyTek Laboratories 0.5 ml 360 EUR

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNCA0047-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), APC conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC810047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF680R conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC810047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF680R conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC800047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF680 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC800047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF680 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC940047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF594 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC940047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF594 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC880047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF488A conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC880047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF488A conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC430047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF543 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC430047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF543 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC400047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF640R conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC400047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF640R conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC050047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF405M conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC050047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF405M conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNCB0047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), Biotin conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNCB0047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), Biotin conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNCAP0047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNCAP0047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNCR0047-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), RPE conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNUB0047-100 Biotium 100uL 250.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), Concentration: 0.2mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNUB0047-500 Biotium 500uL 549.6 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), Concentration: 0.2mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNCP0047-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), PerCP conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNCH0047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNCH0047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNUM0047-50 Biotium 50uL 474 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), 1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC040047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF405S conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC040047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF405S conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC550047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF555 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC550047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF555 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC610047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF660R conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC610047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF660R conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC680047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF568 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC680047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF568 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC470047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF647 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC470047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF647 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC700047-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF770 conjugate, Concentration: 0.1mg/mL

Plasma Cell Marker(LIV3G11 (7B18)) Antibody

BNC700047-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Plasma Cell Marker(LIV3G11 (7B18)), CF770 conjugate, Concentration: 0.1mg/mL

CD5 (Mantel Cell Lymphoma Marker); 4C7

A20090 ScyTek Laboratories 2 ml 216 EUR

CD5 (Mantel Cell Lymphoma Marker); 4C7

A00090.0025 ScyTek Laboratories 25 ml 1150.8 EUR

CD5 (Mantel Cell Lymphoma Marker); 4C7

A00090.050 ScyTek Laboratories 50 ml 1806 EUR

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC941491-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF594 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC941491-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF594 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC941492-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF594 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC941492-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF594 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC801491-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF680 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC801491-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF680 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC801492-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF680 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC801492-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF680 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC811491-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF680R conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC811491-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF680R conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC811492-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF680R conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC811492-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF680R conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC701491-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF770 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC701491-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF770 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC701492-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF770 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC701492-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF770 conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC881491-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF488A conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC881491-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF488A conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC881492-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF488A conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC881492-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF488A conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC051491-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF405M conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC051491-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF405M conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC051492-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF405M conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC051492-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF405M conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC041491-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF405S conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC041491-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF405S conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC041492-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF405S conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1492) Antibody

BNC041492-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1492),CF405S conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC401491-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF640R conjugate, Concentration: 0.1mg/mL

PAX8 (Renal Cell Marker) (PAX8/1491) Antibody

BNC401491-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against PAX8 (Renal Cell Marker) (PAX8/1491),CF640R conjugate, Concentration: 0.1mg/mL

FGDs showed that the need to hide from others to avoid sharing and undesirable effects were other constraints on RUF feeding.This study revealed several factors reducing the acceptability and adherence to RUF therapy based on WHO guidelines in HIV-infected adolescents.

Tailoring prescription guidance and empowering young patients in their care are crucial levers for improving the acceptability of RUF-based therapy in routine care.ClinicalTrials.gov identifier